Richard B. B. Lipton, MD

Professor and Vice Chair of Neurology, Professor of Epidemiology and Population Health
Albert Einstein College of Medicine
Bronx, New York

Disclosure information not submitted.

Presentation(s):

• Efficacy of Zavegepant Nasal Spray for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials

  POSTER ABSTRACT

• Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial

  POSTER ABSTRACT

• Long-Term Safety of Zavegepant Nasal Spray in Patients with Migraine and Cardiovascular Risk Factors

  POSTER ABSTRACT

• Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study

  POSTER ABSTRACT